178 related articles for article (PubMed ID: 32781184)
1. Treatment approaches and outcomes associated with the use of abobotulinumtoxinA for the treatment of hyperhidrosis: A systematic review.
Galadari H; Galadari I; Smit R; Prygova I; Redaelli A
J Am Acad Dermatol; 2021 Nov; 85(5):1121-1129. PubMed ID: 32781184
[TBL] [Abstract][Full Text] [Related]
2. Use of AbobotulinumtoxinA for Cosmetic Treatments in the Neck, and Middle and Lower Areas of the Face: A Systematic Review.
Galadari H; Galadari I; Smit R; Prygova I; Redaelli A
Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33671800
[TBL] [Abstract][Full Text] [Related]
3. Evidence-based medicine: botulinum toxin in focal hyperhidrosis.
Naumann M
J Neurol; 2001 Apr; 248 Suppl 1():31-3. PubMed ID: 11357238
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
Rosell K; Hymnelius K; Swartling C
Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hyperhidrosis with botulinum toxin.
Doft MA; Hardy KL; Ascherman JA
Aesthet Surg J; 2012 Feb; 32(2):238-44. PubMed ID: 22328694
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin: Pharmacology and injectable administration for the treatment of primary hyperhidrosis.
Nawrocki S; Cha J
J Am Acad Dermatol; 2020 Apr; 82(4):969-979. PubMed ID: 31811879
[TBL] [Abstract][Full Text] [Related]
7. Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders.
Naumann M; Dressler D; Hallett M; Jankovic J; Schiavo G; Segal KR; Truong D
Toxicon; 2013 Jun; 67():141-52. PubMed ID: 23178324
[TBL] [Abstract][Full Text] [Related]
8. A preliminary study of painless and effective transdermal botulinum toxin A delivery by jet nebulization for treatment of primary hyperhidrosis.
Iannitti T; Palmieri B; Aspiro A; Di Cerbo A
Drug Des Devel Ther; 2014; 8():931-5. PubMed ID: 25075176
[TBL] [Abstract][Full Text] [Related]
9. Thoracoscopic sympathectomy for palmar and axillary hyperhidrosis: four-year outcome and quality of life after bilateral 5-mm dual port approach.
Bachmann K; Standl N; Kaifi J; Busch P; Winkler E; Mann O; Izbicki JR; Strate T
Surg Endosc; 2009 Jul; 23(7):1587-93. PubMed ID: 19259731
[TBL] [Abstract][Full Text] [Related]
10. Botulinum Toxin Treatment of Autonomic Disorders: Focal Hyperhidrosis and Sialorrhea.
Hosp C; Naumann MK; Hamm H
Semin Neurol; 2016 Feb; 36(1):20-8. PubMed ID: 26866492
[TBL] [Abstract][Full Text] [Related]
11. Interventional management of hyperhidrosis in secondary care: a systematic review.
Wade R; Llewellyn A; Jones-Diette J; Wright K; Rice S; Layton AM; Levell NJ; Craig D; Woolacott N
Br J Dermatol; 2018 Sep; 179(3):599-608. PubMed ID: 29573391
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of botulinum toxin type A local injection therapy for head and forehead hyperhidrosis.
Ando Y; Ohshima Y; Yanagishita T; Watanabe H; Tamada Y; Akiyama M; Watanabe D
J Dermatol; 2022 Jul; 49(7):719-723. PubMed ID: 35393718
[TBL] [Abstract][Full Text] [Related]
13. [Botulinum toxin in the treatment of focal hyperhidrosis].
Schnider P; Moraru E; Kittler H; Voller B; Kranz G; Auff E
Wien Klin Wochenschr; 2001; 113 Suppl 4():36-41. PubMed ID: 15506051
[TBL] [Abstract][Full Text] [Related]
14. Progress and lack of progress in hyperhidrosis research 2015-2020. A concise systematic review.
Kristensen JK; Nielsen C
Int J Dermatol; 2022 Feb; 61(2):148-157. PubMed ID: 34080686
[TBL] [Abstract][Full Text] [Related]
15. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Naumann M; So Y; Argoff CE; Childers MK; Dykstra DD; Gronseth GS; Jabbari B; Kaufmann HC; Schurch B; Silberstein SD; Simpson DM;
Neurology; 2008 May; 70(19):1707-14. PubMed ID: 18458231
[TBL] [Abstract][Full Text] [Related]
16. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
Vergilis-Kalner IJ
J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
[TBL] [Abstract][Full Text] [Related]
17. The use of botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome.
Glaser DA
Neurotox Res; 2006 Apr; 9(2-3):173-7. PubMed ID: 16785115
[TBL] [Abstract][Full Text] [Related]
18. CT-Guided Chemical Thoracic Sympathectomy versus Botulinum Toxin Type A Injection for Palmar Hyperhidrosis.
Yang H; Kang J; Zhang S; Peng K; Deng B; Cheng B
Thorac Cardiovasc Surg; 2019 Aug; 67(5):402-406. PubMed ID: 30216949
[TBL] [Abstract][Full Text] [Related]
19. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial.
Naumann MK; Hamm H; Lowe NJ;
Br J Dermatol; 2002 Dec; 147(6):1218-26. PubMed ID: 12452874
[TBL] [Abstract][Full Text] [Related]
20. Lower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase.
Karamfilov T; Konrad H; Karte K; Wollina U
Arch Dermatol; 2000 Apr; 136(4):487-90. PubMed ID: 10768647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
